Ligand-targeted liposomal anticancer drugs

Antibody or ligand-mediated targeting of liposomal anticancer drugs to antigens expressed selectively or over-expressed on tumor cells is increasingly being recognized as an effective strategy for increasing the therapeutic indices of anticancer drugs. This review summarizes some recent advances in...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Progress in Lipid Research 2003-09, Vol.42 (5), p.439-462
Hauptverfasser:	Sapra, P., Allen, T.M.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies Antibodies, Neoplasm - administration & dosage Antineoplastic Agents - administration & dosage Cancer Doxorubicin Drug Delivery Systems Drug Resistance, Neoplasm Drug targeting Humans Immunoconjugates - administration & dosage Ligands Liposomes Neoplasms - drug therapy Receptor ligands
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!